(Corrects headline and fifth paragraph to say the one-off gain was from a fair value change in Biocon's investment in Equillium, not from a stake sale)
(Reuters) - Indian biotechnology company Biocon Ltd posted an over five-fold rise in second-quarter profit on Thursday, as the company recorded a one-off gain of 1.89 billion rupees ($25.79 million).
Profit was 3.55 billion rupees for the quarter ended Sept. 30, compared with a profit of 688 million rupees a year earlier, Biocon said.
Analysts on average had expected a profit of 1.33 billion rupees, according to Refinitiv data.
Revenue from operations rose over 36 percent to 13.21 billion rupees.
The one-off item includes gains from a change in the fair value of Biocon's investment in Equillium Inc after the U.S. company debuted on the stock market.
($1 = 73.2750 Indian rupees)
(Reporting by Tanvi Mehta in Bengaluru)
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app